Fever, rash, and pancytopenia following vancomycin rechallenge in the presence of ceftazidime.
Shahar
A
A
Berner
Y
Y
Levi
S
S
D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002442:Ceftazidime / Q000009:adverse effects* / Q000627:therapeutic use; D002511:Cephalosporins / Q000009:adverse effects* / Q000627:therapeutic use; D004342:Drug Hypersensitivity / Q000503:physiopathology*; D004347:Drug Interactions; D005076:Exanthema / Q000139:chemically induced* / Q000503:physiopathology; D005260:Female; D005334:Fever / Q000139:chemically induced* / Q000503:physiopathology; D006801:Humans; D010198:Pancytopenia / Q000139:chemically induced* / Q000503:physiopathology; D014640:Vancomycin / Q000009:adverse effects* / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D014640:Vancomycin; D002442:Ceftazidime